Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Altman taps a leading researcher for his brain-computer interface startup, suggesting a much less invasive approach than Elon Musk’s Neuralink. Altman taps a leading researcher for his brain-computer ...

I would like to add the most famous problem of the interviews and different coding platforms as it comes as the daily challenge on platforms and we can only perform the merge sort on the linked list ...

Elon University and Queens University of Charlotte, private institutions roughly two hours apart, announced Tuesday that they plan to merge, with more details to come in the next few months. Although ...

Move expected to enable combined company to serve customers more efficiently, lower grocery prices Complementary Food Distribution Networks to Better Support Independent Retailers: The combined ...

During the last three months, 4 analysts shared their evaluations of Recursion Pharmaceuticals (NASDAQ:RXRX), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

America’s cable giants are being squeezed from all sides. Competition from wireless carriers is surging. Government subsidies are on hold. The onetime fortress of cable TV has all but crumbled.

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it narrows its focus on R&D in oncology and rare diseases. The move comes roughly ...

GRAND RAPIDS, Mich. — If you've been stuck in traffic during construction, you may have noticed cars speeding by in the lane about to end. It may feel unfair, but that move — using both lanes until ...